university of california san francisco

Big jolt to state economy with new tax on cigarettes

EurekAlert! - Cancer  Sun, 02/05/2012 - 23:00

(University of California - San Francisco) A new UCSF analysis has found that a state ballot initiative to increase the cigarette tax would create about 12,000 jobs and nearly $2 billion in new economic activity in California.


 

Vigorous exercise linked to gene activity in prostate

EurekAlert! - Cancer  Tue, 01/31/2012 - 23:00

(University of California - San Francisco) Scientists at the University of California, San Francisco have identified nearly 200 genes in the healthy prostate tissue of men with low-grade prostate cancer that may help explain how physical activity improves survival from the disease.


 

Flatworm flouts fundamental rule of biology

EurekAlert! - Medicine and Health  Wed, 01/04/2012 - 23:00

(University of California - San Francisco) A tiny, freshwater flatworm found in ponds and rivers around the world that has long intrigued scientists for its remarkable ability to regenerate has now added a new wrinkle to biology.


 

Breakthrough in treatment to prevent blindness

EurekAlert! - Infectious and Emerging Diseases  Tue, 12/20/2011 - 23:00

(University of California - San Francisco) A UCSF study shows a popular treatment for a potentially blinding eye infection is just as effective if given every six months versus annually.

This randomized study on trachoma, the leading cause of infection-caused blindness in the world, could potentially treat twice the number of patients using the same amount of medication.


 

UCSF-led team discovers cause of rare disease

EurekAlert! - Medicine and Health  Thu, 12/15/2011 - 23:00

(University of California - San Francisco) A large, international team of researchers led by scientists at the University of California, San Francisco has identified the gene that causes a rare childhood neurological disorder called PKD/IC, or "paroxysmal kinesigenic dyskinesia with infantile convulsions," a cause of epilepsy in babies and movement disorders in older children.


 

UCSF study finds medical marijuana could help patients reduce pa...

EurekAlert! - Cancer  Mon, 12/05/2011 - 23:00

(University of California - San Francisco) A UCSF study suggests patients with chronic pain may experience greater relief if their doctors add cannabinoids - the main ingredient in cannabis or medical marijuana - to an opiates-only treatment.

The findings, from a small-scale study, also suggest that a combined therapy could result in reduced opiate dosages.


 

Tamoxifen resistance -- and how to defeat it

EurekAlert! - Cancer  Sat, 11/12/2011 - 23:00

(University of California - San Francisco) In the last three decades, thousands of women with breast cancer have taken the drug tamoxifen, only to discover that the therapy doesn't work, either because their tumors do not respond to the treatment at all, or because they develop resistance to it over time.

Now researchers at the University of California, San Francisco (UCSF) have discovered the molecular basis for tamoxifen resistance and found a potential way to defeat it.


 

New drug shows promise against multiple sclerosis

EurekAlert! - Medicine and Health  Mon, 10/31/2011 - 22:00

(University of California - San Francisco) An experimental drug called Ocrelizumab has shown promise in a phase two clinical trial involving 220 people with multiple sclerosis, an often debilitating, chronic autoimmune disease that affects an increasing number of people in North America.

It usually strikes young adults and is more common in women than in men.


 

UCSF-Pfizer partnership yields projects aimed at clinical trials

EurekAlert! - Medicine and Health  Tue, 10/25/2011 - 22:00

(University of California - San Francisco) An 11-month-old partnership between UCSF and Pfizer Inc., aimed at rapidly moving new therapies into human clinical trials, has selected its first projects for funding and joint development.


 

Clinical trial shows first evidence that anal cancer is preventa...

EurekAlert! - Cancer  Tue, 10/25/2011 - 22:00

(University of California - San Francisco) A large, international clinical trial led by doctors at the University of California, San Francisco indicates that a vaccine to prevent anal cancer is safe and effective, according to a study reported in the Oct. 27, 2011 issue of New England Journal of Medicine.